Kyverna Therapeutics, Inc. SC 13D and SC 13D/A reports

Location
5980 Horton Street, Suite 550, Emeryville, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
9/17/2024, 01:30 AM
Form type Sec Links Description Filing date Reporting date
SC 13D Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP May 3, 2024